Applications · clinical evidence & program landscape
Applications: where oxygen-delivery science meets clinical need.
A clinical layer above the BHOC and HBOC evidence library. Start with a clinical problem, then move to real-world programs, unmet gaps and the evidence behind Precision Oxygen Therapeutics. Current live directions: Prehospital EMS and Postpartum Hemorrhage (PPH).
Existing evidence stays in placeNo duplicate libraryPrograms + case studies addedLiving updates by direction
Application areas
One platform. Different oxygen-critical problems.
Each direction links back to the existing source library, then adds program intelligence, clinical context and a defined research question.
Microvascular obstruction, anemia and tissue hypoxia viewed through the interaction between oxygen delivery, hemoglobin biology and existing care pathways.
Related evidence49 hematology recordsCore questionHypoxia in vaso-occlusion
These application pages connect BHOC and historical HBOC / Hemopure oxygen-carrier evidence with real-world gaps in blood access, emergency transport and tissue oxygenation.
Evidence boundary: catalogue counts describe related evidence records, not disease-specific proof of efficacy. Published clinical directions link to dedicated evidence pages; future directions remain clearly separated until ready.
Example direction / Prehospital & EMS
From prehospital blood transfusion to prehospital Precision Oxygen Therapeutics - a sustainability solution for timely oxygen delivery.
A sustainability solution for timely oxygen delivery before definitive hospital care.
Clinical problemWhy it mattersCurrent programsExisting evidenceUnresolved gapBHOC relevanceCase study
01 / Why this matters
The treatment clock starts before the hospital.
Severe hemorrhage creates a period in which circulating volume, oxygen-carrying capacity, perfusion and transport time interact. The prehospital question is therefore not only whether transfusion is clinically valuable, but how oxygen-carrying support can be delivered safely across very different EMS environments.
Distance and time to definitive care
Blood storage, inventory and wastage constraints
Compatibility and operational requirements
Ground EMS, air medical, military and rural differences
Need for evidence-linked endpoints beyond a single hemoglobin value
02 / Program landscape
Track what is actually being implemented.
Instead of a static list of articles, each clinical vertical would maintain a dated, source-linked map of programs, guidance, reimbursement changes, pilots and operational models.
Ground EMSBlood-on-ambulance programs
Program name · geography · blood product · start/status · source · last checked.
Air medicalHelicopter / critical care transport
Operational model, storage approach, transfusion protocol and evidence source.
MilitaryBattlefield resuscitation
Doctrine, product logistics, research programs and relevant publications.
Access gapRural / humanitarian systems
Where blood infrastructure is limited and transport-to-care intervals are prolonged.
03 / Evidence already in BHOC-platform
Reuse the library. Do not duplicate it.
The clinical page becomes an intelligent index into the evidence already collected.
Show the exact point where the clinical gap appears.
A simple visual pathway makes the application logic understandable to clinicians, partners and non-specialists without turning the page into marketing.
01Severe injury / hemorrhage
02Reduced circulating O₂ capacity
03Transport interval
04Blood availability decision
Research pointComplementary oxygen-delivery option?
06Hospital / definitive control
07Outcome + tissue endpoints
Reusable template
The same logic for every direction.
SCD, PPH, diabetic foot and tumor hypoxia can use the same architecture while keeping their clinical questions and evidence boundaries distinct.
01Clinical problem
02Why it matters
03Programs & activity
04Existing evidence
05Unresolved gap
06BHOC relevance
07Case study / endpoints
Scientific and educational information; not clinical advice. Clinical evidence, program status and regulatory claims should remain source-linked, jurisdiction-specific and date-stamped. BHOC relevance should be framed as a research or development question unless supported by product-specific clinical evidence.